HKSE:2359

WuXi AppTec Co., Ltd. · HKSE · Healthcare · HKD · FY for 2025

Figures on this page computed 2026-11-08 13:20 UTC

Last close

n/aHKD

Market data

  • 24.6xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    HKD
    • computed
    • Computed from the filing for 2025
  • 26.0%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    HKD
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 42.1%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    HKD
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 25.7%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    HKD
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 0.10Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    HKD
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    HKD
    • computed

Five bars, one line

lens 7 of 9
1.89x
3.12x
4.14x
2.01x
n/a
SalesProfitFree cash flowDebtPrice
Each bar against this company's own average; the line is that average.
Computed2025
Computed2025
Computed2025
Computed2025
Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

  • Sales1.89x

    Its own average over 10 years, 24.02B.

  • Profit3.12x

    Its own average over 10 years, 6.14B.

  • Free cash flow4.14x

    Its own average over 10 years, 2.82B.

  • Debt2.01x

    Its own average over 10 years, 4.11B.

  • Pricen/a

    Its own average over 0 years. Market data

Free cash flow is furthest from its own average, at 4.14 times.

Sales is 1.89 times its own 10-year average; Profit is 3.12 times its own 10-year average; Free cash flow is 4.14 times its own 10-year average; Debt is 2.01 times its own 10-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

  • Sales against its own 10-year average1.89
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CNY
  • Profit against its own 10-year average3.12
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CNY
  • Free cash flow against its own 10-year average4.14
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CNY
  • Debt against its own 10-year average2.01
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CNY
  • Price against its own 0-year averagen/aMarket data

    Not held.

    Source
    market
    Reported in
    HKD

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.